Details:

Alternative Title:
Int J Cancer
Personal Author:
Præstegaard, Camilla ; Jensen, Allan ; Jensen, Signe M. ; Nielsen, Thor S. S. ; Webb, Penelope M. ; ... More +
Præstegaard, Camilla ; Jensen, Allan ; Jensen, Signe M. ; Nielsen, Thor S. S. ; Webb, Penelope M. ; Nagle, Christina M. ; DeFazio, Anna ; Høgdall, Estrid ; Rossing, Mary Anne ; Doherty, Jennifer A. ; Wicklund, Kristine G. ; Goodman, Marc T. ; Modugno, Francesmary ; Moysich, Kirsten ; Ness, Roberta B. ; Edwards, Robert ; Matsuo, Keitaro ; Hosono, Satoyo ; Goode, Ellen L. ; Winham, Stacey J ; Fridley, Brooke L. ; Cramer, Daniel W. ; Terry, Kathryn L. ; Schildkraut, Joellen M. ; Berchuck, Andrew ; Bandera, Elisa V. ; Paddock, Lisa E. ; Massuger, Leon F. ; Wentzensen, Nicolas ; Pharoah, Paul ; Song, Honglin ; Whittemore, Alice ; McGuire, Valerie ; Sieh, Weiva ; Rothstein, Joseph ; Anton-Culver, Hoda ; Ziogas, Argyrios ; Menon, Usha ; Gayther, Simon A. ; Ramus, Susan J. ; Gentry-Maharaj, Alexandra ; Wu, Anna H. ; Pearce, Celeste L. ; Pike, Malcolm ; Lee, Alice W. ; Sutphen, Rebecca ; Chang-Claude, Jenny ; Risch, Harvey A. ; Kjaer, Susanne K. Less -
Corporate Authors:
on behalf of the Australian Ovarian Cancer Study Group
Description:
Cigarette smoking is associated with an increased risk of developing mucinous ovarian tumors but whether it is associated with ovarian cancer survival overall or for the different histotypes is unestablished. Furthermore, it is unknown whether the association between cigarette smoking and survival differs according to strata of ovarian cancer stage at diagnosis. In a large pooled analysis, we evaluated the association between various measures of cigarette smoking and survival among women with epithelial ovarian cancer. We obtained data from 19 case-control studies in the Ovarian Cancer Association Consortium (OCAC), including 9,114 women diagnosed with ovarian cancer. Cox regression models were used to estimate adjusted study-specific hazard ratios (HRs), which were combined into pooled hazard ratios (pHR) with corresponding 95% confidence intervals (CIs) under random effects models. Overall, 5,149 (57%) women died during a median follow-up period of 7.0 years. Among women diagnosed with ovarian cancer, both current (pHR = 1.17, 95% CI: 1.08-1.28) and former smokers (pHR = 1.10, 95% CI: 1.02-1.18) had worse survival compared with never smoking women. In histotype-stratified analyses, associations were observed for mucinous (current smoking: pHR = 1.91, 95% CI: 1.01-3.65) and serous histotypes (current smoking: pHR = 1.11, 95% CI: 1.00-1.23; former smoking: pHR = 1.12, 95% CI: 1.04-1.20). Further, our results suggested that current smoking has a greater impact on survival among women with localized than disseminated disease. The identification of cigarette smoking as a modifiable factor associated with survival has potential clinical importance as a focus area to improve ovarian cancer prognosis.
Subject:
[+]
Adult
Aged
Aged, 80 And Over
Carcinoma, Ovarian Epithelial
Case-Control Studies
Female
Humans
Middle Aged
Neoplasms, Glandular And Epithelial
Ovarian Neoplasms
Proportional Hazards Models
Risk Factors
Smoking
Tobacco
Young Adult

Source:
Int J Cancer. 140(11):2422-2435
Pubmed ID:
28063166
Pubmed Central ID:
PMC5489656
Document Type:
Journal Article
Funding:
U58 DP003931/DP/NCCDPHP CDC HHS/United States ; U01 CA069417/CA/NCI NIH HHS/United States ; P30 ES007048/ES/NIEHS NIH HHS/United States ; N01 PC067010/PC/NCI NIH HHS/United States ; P50 CA159981/CA/NCI NIH HHS/United States ; ... More +
U58 DP003931/DP/NCCDPHP CDC HHS/United States ; U01 CA069417/CA/NCI NIH HHS/United States ; P30 ES007048/ES/NIEHS NIH HHS/United States ; N01 PC067010/PC/NCI NIH HHS/United States ; P50 CA159981/CA/NCI NIH HHS/United States ; P30 CA016056/CA/NCI NIH HHS/United States ; R01 CA087538/CA/NCI NIH HHS/United States ; R01 CA106414/CA/NCI NIH HHS/United States ; M01 RR000056/RR/NCRR NIH HHS/United States ; P30 CA072720/CA/NCI NIH HHS/United States ; C490/A10119 /Cancer Research UK/United Kingdom ; R03 CA113148/CA/NCI NIH HHS/United States ; R01 CA058598/CA/NCI NIH HHS/United States ; K22 CA138563/CA/NCI NIH HHS/United States ; R01 CA058860/CA/NCI NIH HHS/United States ; C490/A10124/Cancer Research UK/United Kingdom ; R01 CA080742/CA/NCI NIH HHS/United States ; R01 CA074850/CA/NCI NIH HHS/United States ; Department of Health/United Kingdom ; K07 CA092044/CA/NCI NIH HHS/United States ; P50 CA105009/CA/NCI NIH HHS/United States ; K07 CA080668/CA/NCI NIH HHS/United States ; P30 CA076292/CA/NCI NIH HHS/United States ; P30 CA014089/CA/NCI NIH HHS/United States ; R01 CA188900/CA/NCI NIH HHS/United States ; R03 CA115195/CA/NCI NIH HHS/United States ; R01 CA054419/CA/NCI NIH HHS/United States ; HHSN261201300021C/CA/NCI NIH HHS/United States ; R01 CA122443/CA/NCI NIH HHS/United States ; P30 CA015083/CA/NCI NIH HHS/United States ; R01 CA076016/CA/NCI NIH HHS/United States ; K07 CA143047/CA/NCI NIH HHS/United States ; P01 CA017054/CA/NCI NIH HHS/United States ; N01 CN025403/CA/NCI NIH HHS/United States ; P30 CA016359/CA/NCI NIH HHS/United States ; K07 CA095666/CA/NCI NIH HHS/United States ; R01 CA112523/CA/NCI NIH HHS/United States ; P50 CA136393/CA/NCI NIH HHS/United States ; 10124/Cancer Research UK/United Kingdom Less -
Collection(s):
CDC Public Access
Main Document Checksum:
[+]
urn:sha256:412e2795a8a4b8f3a6523fc39ece35e10a59d0a4d2858d244ccac0657b984a95
File Type:

Supporting Files

• 	NIHMS868297-supplement-Supp_Tbl_1.docx	docx
  	NIHMS868297-supplement-Supp_Tbl_2.docx	docx
  	NIHMS868297-supplement-Supp_Tbl_3.docx	docx
  	NIHMS868297-supplement-Supp_Tbl_4.docx	docx
  	nihms868297.nxml	xml
  	nihms868297f1.gif	gif
  	nihms868297f1.jpg	jpeg

More +